156 related articles for article (PubMed ID: 10537321)
21. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.
Mason KA; Ariga H; Neal R; Valdecanas D; Hunter N; Krieg AM; Whisnant JK; Milas L
Clin Cancer Res; 2005 Jan; 11(1):361-9. PubMed ID: 15671567
[TBL] [Abstract][Full Text] [Related]
22. The effect of irradiation on mitotic and apoptotic frequency in head and neck cancer cell lines, the correlation to p53 mutations and clonogenic survival.
Pulkkinen JO; Servomaa K; Pekkola K; Kulmala J; Grenman R
Anticancer Res; 2000; 20(3A):1503-11. PubMed ID: 10928063
[TBL] [Abstract][Full Text] [Related]
23. Initial slope of radiation survival curves is characteristic of the origin of primary and established cultures of human tumor cells and fibroblasts.
Malaise EP; Fertil B; Deschavanne PJ; Chavaudra N; Brock WA
Radiat Res; 1987 Aug; 111(2):319-33. PubMed ID: 3628719
[TBL] [Abstract][Full Text] [Related]
24. Low dose of wortmannin reduces radiosensitivity of human glioblastoma cells through the p53 pathway.
Okaichi K; Suzuki K; Morita N; Ikeda M; Takahashi H; Matsuda N; Watanabe M; Okumura Y
Oncol Rep; 2002; 9(4):859-62. PubMed ID: 12066222
[TBL] [Abstract][Full Text] [Related]
25. Reoxygenation of hypoxic cells by tumor shrinkage during irradiation. A computer simulation.
Kocher M; Treuer H
Strahlenther Onkol; 1995 Apr; 171(4):219-30. PubMed ID: 7740410
[TBL] [Abstract][Full Text] [Related]
26. Oxygenation status and tumor response during fractionated irradiation in two murine tumor cell lines of same origin but different intrinsic radiosensitivities.
Mariya Y; Seinberg F; Streffer C; Fuhrmann C; Abe Y
Radiat Med; 1999; 17(2):175-9. PubMed ID: 10399788
[TBL] [Abstract][Full Text] [Related]
27. Influence of p53 status on radiation and 5-flourouracil synergy in pancreatic cancer cells.
Mohiuddin M; Chendil D; Dey S; Alcock RA; Regine W; Mohiuddin M; Ahmed MM
Anticancer Res; 2002; 22(2A):825-30. PubMed ID: 12014658
[TBL] [Abstract][Full Text] [Related]
28. Evidence that individual variations in TP53 and CDKN1A protein responsiveness are related to inherent radiation sensitivity.
Alsbeih G; Torres M; Al-Harbi N; Al-Buhairi M
Radiat Res; 2007 Jan; 167(1):58-65. PubMed ID: 17214516
[TBL] [Abstract][Full Text] [Related]
29. Effect of radiation on cytokine and cytokine receptor messenger-RNA profiles in p53 wild and mutated human glioblastoma cell lines.
Yee D; Hao C; Cheung HC; Chen HT; Dabbagh L; Hanson J; Coupland R; Petruk KC; Fulton D; Roa WH
Clin Invest Med; 2001 Apr; 24(2):76-82. PubMed ID: 11368149
[TBL] [Abstract][Full Text] [Related]
30. Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation.
Yaromina A; Krause M; Thames H; Rosner A; Krause M; Hessel F; Grenman R; Zips D; Baumann M
Radiother Oncol; 2007 Jun; 83(3):304-10. PubMed ID: 17517444
[TBL] [Abstract][Full Text] [Related]
31. A p53 and apoptotic independent role for p21waf1 in tumour response to radiation therapy.
Wouters BG; Denko NC; Giaccia AJ; Brown JM
Oncogene; 1999 Nov; 18(47):6540-5. PubMed ID: 10597257
[TBL] [Abstract][Full Text] [Related]
32. Intrinsic radiosensitivity and repair of sublethal radiation-induced damage in canine osteosarcoma cell lines.
Fitzpatrick CL; Farese JP; Milner RJ; Salute ME; Rajon DA; Morris CG; Bova FJ; Lurie DM; Siemann DW
Am J Vet Res; 2008 Sep; 69(9):1197-202. PubMed ID: 18764694
[TBL] [Abstract][Full Text] [Related]
33. Fractionated X-radiation treatment can elicit an inducible-like radioprotective response that is not dependent on the intrinsic cellular X-radiation resistance/sensitivity.
Qutob SS; Multani AS; Pathak S; McNamee JP; Bellier PV; Liu QY; Ng CE
Radiat Res; 2006 Oct; 166(4):590-9. PubMed ID: 17007548
[TBL] [Abstract][Full Text] [Related]
34. Lack of P-glycoprotein expression by low-dose fractionated radiation results from loss of nuclear factor-kappaB and NF-Y activation in oral carcinoma cells.
Shareef MM; Brown B; Shajahan S; Sathishkumar S; Arnold SM; Mohiuddin M; Ahmed MM; Spring PM
Mol Cancer Res; 2008 Jan; 6(1):89-98. PubMed ID: 18234965
[TBL] [Abstract][Full Text] [Related]
35. Radiation-induced apoptosis and cell cycle alterations in human carcinoma cell lines with different radiosensitivities.
Hunáková L; Chorváth M; Duraj J; Bartosová Z; Sevcíková L; Suliková M; Chovancová J; Sedlák J; Chorváth B; Boljesíková E
Neoplasma; 2000; 47(1):25-31. PubMed ID: 10870683
[TBL] [Abstract][Full Text] [Related]
36. Activation of nuclear factor kappaB in radioresistance of TP53-inactive human keratinocytes.
Chen X; Shen B; Xia L; Khaletzkiy A; Chu D; Wong JY; Li JJ
Cancer Res; 2002 Feb; 62(4):1213-21. PubMed ID: 11861406
[TBL] [Abstract][Full Text] [Related]
37. Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec).
Oertel S; Krempien R; Lindel K; Zabel A; Milker-Zabel S; Bischof M; Lipson KE; Peschke P; Debus J; Abdollahi A; Huber PE
Strahlenther Onkol; 2006 Jul; 182(7):400-7. PubMed ID: 16826359
[TBL] [Abstract][Full Text] [Related]
38. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ
Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751
[TBL] [Abstract][Full Text] [Related]
39. Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo.
Burns TF; Bernhard EJ; El-Deiry WS
Oncogene; 2001 Aug; 20(34):4601-12. PubMed ID: 11498783
[TBL] [Abstract][Full Text] [Related]
40. Effects of the protein kinase inhibitors wortmannin and KN62 on cellular radiosensitivity and radiation-activated S phase and G1/S checkpoints in normal human fibroblasts.
Enns L; Murray D; Mirzayans R
Br J Cancer; 1999 Nov; 81(6):959-65. PubMed ID: 10576651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
